Kobo Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

23.83

23.83

23.83

23.83

23.83

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-151.81

-146.25

-131.03

-111.80

-90.79

Loan funds

Secured loans

139.84

140.72

208.26

198.86

184.46

Unsecured loans

-

-

-

-

-

Total

11.86

18.29

101.06

110.89

117.50

Uses of funds

Fixed assets

Gross block

103.68

103.68

192.42

192.42

192.42

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

66.09

62.02

135.51

129.88

124.00

Net block

37.59

41.66

56.91

62.54

68.42

Capital work-in-progress

-

-

2.25

2.25

2.25

Investments

-

-

12.19

12.19

12.19

Net current assets

Current assets, loans & advances

37.74

37.53

159.24

159.35

156.58

Less : current liabilities & provisions

63.47

60.90

129.53

125.44

121.95

Total net current assets

-25.73

-23.37

29.71

33.90

34.63

Miscellaneous expenses not written

-

-

-

-

-

Total

11.86

18.29

101.06

110.89

117.50

Notes:

Book value of unquoted investments

-

-

12.19

12.19

12.19

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

238.25

238.25

238.25

238.25

238.25